New antibiotics take aim at staph's rise

Wall Street Journal (subscription required), November 18, 2008

A Food and Drug Administration advisory panel will consider three proposed antibiotics designed to treat serious skin infections, including some caused by MRSA. The bacterium has sparked concern as the super bug has moved into community settings like schools and locker rooms in recent years after once being largely confined to hospital settings. But it's not clear if any of the three drugs will reach the bar for FDA approval because of safety concerns or questions about how well the drugs work compared with other available medications.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.